FI913431A - Antagonister av pyrazolidinon cck och gastrin och dessa innehaollande farmaceutiska kompositioner. - Google Patents

Antagonister av pyrazolidinon cck och gastrin och dessa innehaollande farmaceutiska kompositioner. Download PDF

Info

Publication number
FI913431A
FI913431A FI913431A FI913431A FI913431A FI 913431 A FI913431 A FI 913431A FI 913431 A FI913431 A FI 913431A FI 913431 A FI913431 A FI 913431A FI 913431 A FI913431 A FI 913431A
Authority
FI
Finland
Prior art keywords
och
antagonister
pyrazolidinon
gastrin
cck
Prior art date
Application number
FI913431A
Other languages
English (en)
Other versions
FI913431A0 (fi
Inventor
Raymond Frank Brown
James Jeffry Howbert
Karen Lynn Lobb
David Andrew Neel
Jon Kevin Reel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI913431A0 publication Critical patent/FI913431A0/fi
Publication of FI913431A publication Critical patent/FI913431A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D231/08Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI913431A 1990-07-17 1991-07-16 Antagonister av pyrazolidinon cck och gastrin och dessa innehaollande farmaceutiska kompositioner. FI913431A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55348990A 1990-07-17 1990-07-17

Publications (2)

Publication Number Publication Date
FI913431A0 FI913431A0 (fi) 1991-07-16
FI913431A true FI913431A (fi) 1992-01-18

Family

ID=24209587

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913431A FI913431A (fi) 1990-07-17 1991-07-16 Antagonister av pyrazolidinon cck och gastrin och dessa innehaollande farmaceutiska kompositioner.

Country Status (19)

Country Link
EP (1) EP0467614A1 (fi)
JP (1) JPH04230367A (fi)
KR (1) KR960005950B1 (fi)
CN (1) CN1032000C (fi)
AU (2) AU644190B2 (fi)
BR (1) BR9103042A (fi)
CA (1) CA2046672A1 (fi)
CS (1) CS219391A3 (fi)
FI (1) FI913431A (fi)
HU (1) HUT58296A (fi)
IE (1) IE912489A1 (fi)
IL (1) IL98785A (fi)
MX (1) MX9100164A (fi)
NO (1) NO912772L (fi)
NZ (1) NZ238912A (fi)
PT (1) PT98323A (fi)
RU (1) RU2076100C1 (fi)
YU (1) YU124391A (fi)
ZA (1) ZA915372B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191084A (en) * 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
US5153191A (en) * 1991-08-20 1992-10-06 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
US5399708A (en) * 1993-11-12 1995-03-21 Eli Lilly And Company Pyrazolidin-3-one derivatives
GB0011095D0 (en) 2000-05-08 2000-06-28 Black James Foundation astrin and cholecystokinin receptor ligands (III)
PE20020856A1 (es) * 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
UA79804C2 (en) 2002-07-03 2007-07-25 Janssen Pharmaceutica Nv Cck-1 receptor modulators
GB0312368D0 (en) * 2003-05-30 2003-07-02 Univ Aston Novel ureido- and amido-pyrazolone derivatives
US8410135B2 (en) * 2007-06-15 2013-04-02 Solvay Pharmaceuticals B.V. 4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
EP3883925A4 (en) * 2018-11-20 2021-12-29 Sironax Ltd Cyclic ureas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE530886A (fi) * 1953-08-03
FR82186E (fr) * 1959-04-10 1964-01-04 Kodak Pathe Nouveau produit photographique et procédé pour le traitement de ce produit
FR2529786A1 (fr) * 1982-07-12 1984-01-13 Nativelle Sa Ets Compositions pharmaceutiques a base de derives de la pyrazolone-5, nouveaux produits et procede de preparation
DE3407506A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoline, verfahren zu ihrer herstellung und deren verwendung
EP0166355A2 (en) * 1984-06-26 1986-01-02 Merck & Co. Inc. Substituted aminophenyl compounds and acylaminophenyl compounds and pharmaceutical compositions containing them
US5089622A (en) * 1988-12-12 1992-02-18 Mitsui Toatsu Chemicals Incorporated (-)-2-pyrazoline compounds and therapeutic agent for cerebrovascular disorders containing the same as effective ingredient
US5191084A (en) * 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents

Also Published As

Publication number Publication date
PT98323A (pt) 1992-06-30
HU912376D0 (en) 1991-12-30
AU8040991A (en) 1992-01-23
RU2076100C1 (ru) 1997-03-27
ZA915372B (en) 1993-03-31
YU124391A (sh) 1994-01-20
KR960005950B1 (ko) 1996-05-06
NO912772L (no) 1992-01-20
IL98785A0 (en) 1992-07-15
NO912772D0 (no) 1991-07-15
CN1058209A (zh) 1992-01-29
BR9103042A (pt) 1992-04-28
AU5529394A (en) 1994-04-28
CS219391A3 (en) 1992-02-19
JPH04230367A (ja) 1992-08-19
CA2046672A1 (en) 1992-01-18
KR920002548A (ko) 1992-02-28
CN1032000C (zh) 1996-06-12
FI913431A0 (fi) 1991-07-16
IL98785A (en) 1995-11-27
AU644190B2 (en) 1993-12-02
MX9100164A (es) 1992-02-28
NZ238912A (en) 1992-12-23
EP0467614A1 (en) 1992-01-22
HUT58296A (en) 1992-02-28
IE912489A1 (en) 1992-01-29

Similar Documents

Publication Publication Date Title
FI913917A0 (fi) 3-amidopyrazolderivat, foerfarande foer framstaellning av dessa och farmaceutiska kompositioner innehaollande dessa.
FI906444A (fi) Paofyllbar polyesterkaerl och foer form foer bildande av detta.
FI914429A0 (fi) Foerfarande och anordning foer optimering av bussarbitration.
FI913871A0 (fi) Saollplaotar och foerfaranden foer framstaellning av dessa.
FI902267A0 (fi) Foerfarande foer paofyllning och toemning av pipett och pipett.
FI913612A0 (fi) Foerfarande foer avskaerning av arbetstycke och anordning foer genomfoerande av foerfarandet.
FI900031A (fi) Foerfarande och anordning foer behandling av gaser fraon foergasnings- eller foerbraenningsanlaeggningar.
FI913913A0 (fi) Stabiliserade klordeoxisockersoetningsmedel och foerfaranden foer framstaellning av dessa.
FI913431A (fi) Antagonister av pyrazolidinon cck och gastrin och dessa innehaollande farmaceutiska kompositioner.
FI911313A0 (fi) Vismutoxidsuperledare och foerfarande foer framstaellning av denna.
FI913888A (fi) Nya farmaceutiska sammansaettningar och foerfarande foer framstaellning av desamma.
FI910324A (fi) Foerfaranden och testfoerpackningar foer detektering av maenniskans leukocytantigen-dna.
FI923120A (fi) Foerfarande och anordning foer kompostering av organiskt avfall.
FI901843A (fi) Foerfarande och anordning foer styrning av raomaterialtillfoerseln till en elektrisk smaeltugn.
FI920866A0 (fi) Foerfarande foer framstaellning av papper och tillsatsaemnen till framstaellningen.
FI905436A (fi) Anordning och foerfarande foer montering av en kranvinkel.
FI906118A (fi) Foerfarande och form foer gjutning av plattbelaeggning.
FI902677A0 (fi) Foerfarande foer aotervinning av alifatiska syror och socker.
FI900168A0 (fi) Foerfarande och anordning foer borning av kanaloeppning.
FI902093A0 (fi) Foerfarande och anordning foer framstaellning av ihaoliga mikrosfaerer.
FI901661A0 (fi) Foerfarande foer installering av borsten till en biltvaettanordningsborste och en enligt foerfarandet framstaelld biltvaettanordningsborste.
FI900640A0 (fi) Foerfarande och anordning foer matning av tillsatsaemne till banan.
FI901350A0 (fi) Foerfarande och anordning foer framstaellning av olika fibermaterial foer spaonplatta- fiberplatta- och traeindustrer.
FI900692A (fi) Foerfarande och anordning foer bekaempning av oljeskador.
FI914529A0 (fi) Foerfarande och anordning foer kontroll av en tyristorlikriktare.

Legal Events

Date Code Title Description
FD Application lapsed